Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers

被引:2
|
作者
Vu, Trung [1 ]
Fowler, Annaliese [2 ]
McCarty, Nami [2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis IMM, Ctr Stem Cell & Regenerat Dis, Houston, TX 77030 USA
[2] Texas A&M Univ, Dept Biomed Engn, Houston, TX 77030 USA
关键词
TP53; liver cancer; TRIM family; cell cycle; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; GENE-EXPRESSION; P53; MICRORNAS; SURVIVAL; PROMOTES; MIR-34A;
D O I
10.3390/cancers15153792
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The p53 protein is an important tumor suppressor, and TP53 mutations are frequently low survival rates of cancer patients. Mutations in TP53 lead in loss of tumor suppressing functions which result in the development of tumors. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the relationship between TRIM family genes and TP53 mutations in cancer remains unknown. In this study, we analyzed the links between TP53 mutations and TRIM family proteins and evaluated the role of TRIM family proteins in cancer patients with TP53 mutation. Our findings identified the TRIM family members that are highly expressed in TP53 mutant tumors and important for the cell growth in the context of TP53 mutations. The p53 protein is an important tumor suppressor, and TP53 mutations are frequently associated with poor prognosis in various cancers. Mutations in TP53 result in a loss of p53 function and enhanced expression of cell cycle genes, contributing to the development and progression of cancer. Meanwhile, several tripartite motif (TRIM) proteins are known to regulate cell growth and cell cycle transition. However, the prognostic values between TP53 and TRIM family genes in cancer are unknown. In this study, we analyzed the relationship between the TP53 mutations and TRIM family proteins and evaluated the prognostic significance of TRIM family proteins in cancer patients with P53 mutations. Our findings identified specific TRIM family members that are upregulated in TP53 mutant tumors and are associated with the activation of genes related to a cell-cycle progression in the context of TP53 mutations.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Clinical Outcomes of TP53 Mutations in Cancers
    Robles, Ana I.
    Jen, Jin
    Harris, Curtis C.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (09):
  • [2] TP53 mutations in human skin cancers
    Giglia-Mari, G
    Sarasin, A
    HUMAN MUTATION, 2003, 21 (03) : 217 - 228
  • [3] Smoking, lung cancers and their TP53 mutations
    Cooper, CS
    MUTAGENESIS, 2002, 17 (04) : 279 - 280
  • [4] TP53 family members and human cancers
    Bénard, J
    Douc-Rasy, S
    Ahomadegbe, JC
    HUMAN MUTATION, 2003, 21 (03) : 182 - 191
  • [5] Context Determines Effects of TP53 Mutations
    Haloupek, Nicole
    CANCER DISCOVERY, 2020, 10 (11) : 1616 - 1616
  • [6] Prediction of TP53 mutations by p53 immunohistochemistry and their prognostic significance in gastric cancer
    Hwang, Hye Jung
    Nam, Soo Kyung
    Park, Hyunjin
    Park, Yujun
    Koh, Jiwon
    Na, Hee Young
    Kwak, Yoonjin
    Kim, Woo Ho
    Lee, Hye Seung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2020, 54 (05) : 7845 - 386
  • [7] Prognostic Significance Of TP53 mutations and Single Nucleotide Polymorphisms In Acute Myeloid Leukemia
    Zeichner, Simon B.
    Alghamdi, Sarah
    Elhammady, Gina
    Poppiti, Robert
    Castellano-Sanchez, Amilcar
    BLOOD, 2013, 122 (21)
  • [8] Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
    Lindenbergh-van der Plas, Marlon
    Brakenhoff, Ruud H.
    Kuik, Dirk J.
    Buijze, Marijke
    Bloemena, Elisabeth
    Snijders, Peter J. F.
    Leemans, C. Rene
    Braakhuis, Boudewijn J. M.
    CLINICAL CANCER RESEARCH, 2011, 17 (11) : 3733 - 3741
  • [9] THE PROGNOSTIC SIGNIFICANCE OF TP53 MUTATIONS IN MDS PATIENTS WITH DEL(5Q)
    Belickova, M.
    Vesela, J.
    Jonasova, A.
    Planetova, B.
    Valka, J.
    Mikulenkova, D.
    Zemanova, Z.
    Brezinova, J.
    Michalova, K.
    Cermak, J.
    LEUKEMIA RESEARCH, 2015, 39 : S22 - S23
  • [10] TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database
    Victor D. Li
    Karen H. Li
    John T. Li
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 625 - 636